Representatives from Lung Cancer Europe at the ESMO 2024
Lung Cancer Europe shared a post on LinkedIn:
“The annual Congress of ESMO – European Society for Medical Oncology takes place from September 13th-17th 2024 in Barcelona.
ESMO2024 will disseminate the latest cutting-edge data, provide high-quality education and excellent networking opportunities for oncologists and other stakeholders from around the world.
It is recognised as a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives.
Representatives from Lung Cancer Europe who will attend this year include:
- Anne-Marie Baird, President, LuCE and Senior Research Fellow at Trinity College Dublin
- Debra Montague, LuCE Vice-President, and Chair ALK Positive Lung Cancer UK
- Lavinia Magee, LuCE Board Member and Lung Cancer Nursing UK (LCNUK)
- Merel Hennink, LuCE Member from Longkanker Nederland
- Filipe Paixão, LuCE Member and European Lung Foundation Patient Advisory Group
- Yvonne Diaz, LuCE Member and Oncogene Cancer Research
- Shani Shilo, LuCE Member and Israeli Lung Cancer Foundation
- Maeve O’Sullivan, LuCE Executive Director
- Alfonso Aguarón, LuCE Policy Officer
- Catriona Grant, LuCE Senior Project Manager
To contact any of these LuCE members in advance of the conference, please email [email protected]
More about ESMO24 here.”
Oncogene Cancer Research shared this post, adding:
“We are thrilled to join our fellow Lung Cancer Europe members in force at the ESMO – European Society for Medical Oncology 2024 conference next month in Barcelona!”
Source: Lung Cancer Europe/LinkedIn and Oncogene Cancer Research/LinkedIn
More posts about ESMO 2024 in OncoDaily.